The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT
Open accessAbstract
UNLABELLED: The aim of this study was to evaluate the diagnostic value of a new somatostatin analog, (68)Ga-labeled 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-d-Phe(1)-Tyr(3)-octreotide ((68)Ga-DOTA-TOC), for PET in patients with known or suspected neuroendocrine tumors. PET was compared with conventional scintigraphy and dedicated CT. METHODS: Eighty-four patients (48 men, 36 women; age range, 28-79 y; mean age +/- SD, 58.2 +/- 12.2 y) were prospectively studied. For analysis, patients were divided into 3 groups: detection of unknown primary tumor in the presence of clinical or biochemical suspicion of neuroendocrine malignancy (n = 13 patients), initial tumor staging (n = 36 patients), and follow-up after therapy (n = 35 patients). Each patient received 100-150 MBq (68)Ga-DOTA-TOC. Imaging results of PET were compared with (99m)Tc-labeled hydrazinonicotinyl-Tyr(3)-octreotide ((99m)Tc-HYNIC-TOC) and (111)In-DOTA-TOC. CT was also performed on every patient using a multidetector scanner. Each imaging modality was interpreted separately by observers who were unaware of imaging findings before comparison with PET. The gold standard for defining true-positive (TP), true-negative (TN), false-positive (FP), and false-negative (FN) results was based on all available histologic, imaging, and follow-up findings. RESULTS: PET was TP in 69 patients, TN in 12 patients, FP in 1 patient, and FN in 2 patients, indicating a sensitivity of 97%, a specificity of 92%, and an accuracy of 96%. The FP finding was caused by enhanced tracer accumulation in the pancreatic head, and the FN results were obtained in patients with a tumor of the gastrointestinal tract displaying liver metastases. (68)Ga-DOTA-TOC showed higher diagnostic efficacy compared with SPECT (TP in 37 patients, TN in 12 patients, FP in 1 patient, and FN in 34 patients) and diagnostic CT (TP in 41 patients, TN in 12 patients, FP in 5 patients, and FN in 26 patients). This difference was of statistical significance (P < 0.001). However, the combined use of PET and CT showed the highest overall accuracy. CONCLUSION: (68)Ga-DOTA-TOC PET shows a significantly higher detection rate compared with conventional somatostatin receptor scintigraphy and diagnostic CT with clinical impact in a considerable number of patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A 5‐decade analysis of 13,715 carcinoid tumors
Modlin, I. M., Lye, K. D., & Kidd, M. (2003) · Cancer · doi:10.1002/cncr.11105 · Cited by 2,734
Krenning, E. P., Kwekkeboom, D. J., Bakker, W. H., Breeman, W. A. P., Kooij, P. P. M., Oei, H. Y., van Hagen, M., Postema, P. T. E., de Jong, M., Reubi, J. C., et al. (1993) · European Journal of Nuclear Medicine · doi:10.1007/bf00181765 · Cited by 1,564
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
Reubi, J. C. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0007 · Cited by 1,131
Hofmann, M., Maecke, H., Börner, A., Weckesser, E., Schöffski, P., Oei, M., Schumacher, J., Henze, M., Heppeler, A., Meyer, G., et al. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590100639 · Cited by 544
Gupta, S., Johnson, M. M., Murthy, R., Ahrar, K., Wallace, M. J., Madoff, D. C., McRae, S. E., Hicks, M. E., Rao, S., Vauthey, J., et al. (2005) · Cancer · doi:10.1002/cncr.21389 · Cited by 433
Panzuto, F., Nasoni, S., Falconi, M., Corleto, V. D., Capurso, G., Cassetta, S., Di Fonzo, M., Tornatore, V., Milione, M., Angeletti, S., et al. (2005) · Endocrine-Related Cancer · doi:10.1677/erc.1.01017 · Cited by 391
Dromain, C., de Baere, T., Lumbroso, J., Caillet, H., Laplanche, A., Boige, V., Ducreux, M., Duvillard, P., Elias, D., Schlumberger, M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.013 · Cited by 389
Adams, S., Baum, R., Rink, T., Schumm-Dräger, P.-M., Usadel, K.-H., & Hör, G. (1997) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050197 · Cited by 387
Peptide receptor imaging and therapy.
Kwekkeboom, D. J., Krenning, E. P., & de Jong, M. (2000) · PubMed · Cited by 330
Orlefors, H., Sundin, A., Garske, U., Juhlin, C., Oberg, K., Skogseid, B., Langstrom, B., Bergstrom, M., & Eriksson, B. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1938 · Cited by 329
Kowalski, J. (2003) · Molecular Imaging & Biology · doi:10.1016/s1536-1632(03)00038-6 · Cited by 304
Radiolabelling DOTA-peptides with 68Ga
Breeman, W. A. P., de Jong, M., de Blois, E., Bernard, B. F., Konijnenberg, M., & Krenning, E. P. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-004-1702-y · Cited by 291
Epidemiology and survival in patients with carcinoid disease in the Netherlands
Quaedvlieg, P. F. H. J., Visser, O., Lamers, C. B. H. W., Janssen-Heijen, M. L. G., & Taal, B. G. (2001) · Annals of Oncology · doi:10.1023/a:1012272314550 · Cited by 260
Receptor Targeting for Tumor Localisation and Therapy with Radiopeptides
Heppeler, A., Froidevaux, S., Eberle, A., & Maecke, H. (2000) · Current Medicinal Chemistry · doi:10.2174/0929867003374516 · Cited by 258
de Jong, M., Bakker, W. H., Krenning, E. P., Breeman, W. A. P., van der Pluijm, M. E., Bernard, B. F., Visser, T. J., Jermann, E., Béhé, M., Powell, P., et al. (1997) · European Journal of Nuclear Medicine · doi:10.1007/bf00881807 · Cited by 215
Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET.
Becherer, A., Szabó, M., Karanikas, G., et al. (2004) · PubMed · Cited by 206
Gabriel, M., Decristoforo, C., Donnemiller, E., Ulmer, H., Rychlinski, C. W., Mather, S. J., & Moncayo, R. (2003) · PubMed · Cited by 169
Self-citationProcedure guideline for somatostatin receptor scintigraphy with (111)In-pentetreotide.
Balon, H. R., Goldsmith, S. J., Siegel, B. A., Silberstein, E. B., Krenning, E. P., Lang, O., & Donohoe, K. J. (2001) · PubMed · Cited by 140
Uğur, Ö., Kothari, P. J., Finn, R. D., ZANZONICO, P. B., Ruan, S., Guenther, I., Maëcke, H. R., & Larson, S. M. (2002) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(01)00290-6 · Cited by 113
Kwekkeboom, D. J., Kooij, P. P. M., Bakker, W., Mäcke, H. R., & Krenning, E. P. (1999) · PubMed · Cited by 106
Imaging appearances of metastases from neuroendocrine tumours of the pancreas
Debray, M., Geoffroy, O., Laissy, J., Lebtahi, R., Silbermann-Hoffman, O., Henry–Feugeas, M.-C., Cadiot, G., Mignon, M., & Schouman‐Claeys, E. (2001) · British Journal of Radiology · doi:10.1259/bjr.74.887.741065 · Cited by 100
Imaging of neuroendocrine tumors: accuracy of helical CT versus SRS.
Kumbasar, B., Kamel, I. R., Tekes, A., Eng, J., Fishman, E. K., & Wahl, R. L. (2004) · Abdominal Imaging · doi:10.1007/s00261-003-0162-3 · Cited by 84
Meisetschläger, G., Poethko, T., Stahl, A. R., Wolf, I., Scheidhauer, K., Schottelius, M., Herz, M., Wester, H. J., & Schwaiger, M. (2006) · PubMed · Cited by 83
Gabriel, M., Hausler, F., Bale, R. J., et al. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1875-z · Cited by 59
Self-citationKrenning, E. P., Kwekkeboom, D. J., de Jong, M., Visser, T. J., Reubi, J. C., Bakker, W. H., Kooij, P. P., & Lamberts, S. W. (1994) · PubMed · Cited by 46
Schillaci, O., Spanu, A., Scopinaro, F., et al. (2003) · International Journal of Oncology · doi:10.3892/ijo.23.6.1687 · Cited by 32
Somatostatin and the concept of peptide receptor scintigraphy in oncology.
Lamberts, S. W. J., Jc, R., & Krenning, E. P. (1994) · PubMed · Cited by 31
Cited by
Gastroenteropancreatic neuroendocrine tumours
Modlin, I. M., Oberg, K., Chung, D. C., Jensen, R. T., de Herder, W. W., Thakker, R. V., Caplin, M., Delle Fave, G., Kaltsas, G. A., Krenning, E. P., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70410-2 · Cited by 1,748
Pavel, M., Öberg, K., Falconi, M., Krenning, E. P., Sundin, A., Perren, A., & Berruti, A. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.03.304 · Cited by 1,179
Matching chelators to radiometals for radiopharmaceuticals
Price, E. W., & Orvig, C. (2014) · Chem. Soc. Rev. · doi:10.1039/c3cs60304k · Cited by 1,018
Ramage, J. K., Ahmed, A., Ardill, J., Bax, N., Breen, D. J., Caplin, M. E., Corrie, P., Davar, J., Davies, A. H., Lewington, V, et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300831 · Cited by 952
Wadas, T. J., Wong, E. H., Weisman, G. R., & Anderson, C. J. (2010) · Chemical Reviews · doi:10.1021/cr900325h · Cited by 924
Metadata
- Authors
- Gabriel, M., Decristoforo, C., Kendler, D., Dobrozemsky, G., Heute, D., Uprimny, C., Kovacs, P., Von Guggenberg, E., Bale, R., & Virgolini, I. J.
- Venue
- Journal of Nuclear Medicine
- Publisher
- Society of Nuclear Medicine
- Published
- 2007-04-01
- Volume
- 48
- Issue
- 4
- Pages
- 508-518
- ISSN
- 0161-5505 (ISSN-L)
- OpenAlex
- W1986723218
- Cited by
- 1,010
- References
- 27
- FWCI
- 34.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.